Table 3.

Distribution of Surgical Complications in Recipients of Neoadjuvant Therapy^a

	No. of Patients (%)
Surgical Complication	No Neoadjuvant, n=485	Neoadjuvant, n=180	P
Anyb	151 (31.1)	54 (30)	.85
Seroma	59 (12.2)	27 (15)	.36
Hematoma	26 (5.4)	5 (2.8)	.21
Surgical site infection	52 (10.7)	18 (10)	.89
Dehiscence/open wound	25 (5.2)	6 (3.3)	.41
Skin necrosis	45 (9.3)	13 (7.2)	.44
Flap failure/loss	1 (0.2)	2 (1.1)	.18
Thromboembolism	3 (0.6)	2 (1.1)	.62
Tissue expander/implant removal	3 (0.6)	0 (0)	.39

^aIn the 60 days after mastectomy.

^b“Any” is not the sum of all complications; some patients developed more than 1 complication.